Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Pomalidomide 4 MG Oral Capsule
DRUG
3 trials
Sponsors
Jiangsu Simcere Pharmaceutical Co., Ltd.
, GWT-TUD GmbH
, Megalabs
Conditions
Bioequivalence
Bioequivalence Study
Refractory Multiple Myeloma
Phase 1
A Pilot Bioequivalence Study of Pomalidomide
Completed
NCT03424928
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bioequivalence
Start: 2018-01-19
End: 2018-02-06
Updated: 2018-02-07
A Pilot Bioequivalence Study of Pomalidomide
NCT06058689
Megalabs
Bioequivalence Study
Start: 2024-09-15
End: 2025-03-15
Target: 10
Updated: 2023-09-28
Phase 2
Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
Completed
NCT03731832
GWT-TUD GmbH
Refractory Multiple Myeloma
Start: 2018-09-20
End: 2024-04-22
Updated: 2025-09-30